Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Nasdaq    NDAQ


Delayed Quote. Delayed Nasdaq - 09/29 04:00:00 pm
121.38 USD   -3.18%
04:31pNASDAQ : to Hold Third Quarter 2020 Investor Conference Call
04:31pNasdaq to Hold Third Quarter 2020 Investor Conference Call
09/25IPO Market Parties Like It's 1999
SummaryAll NewsPress ReleasesOfficial PublicationsSector news

Nasdaq-Owned Danish Market Is Thriving -- WSJ

share with twitter share with LinkedIn share with facebook
08/04/2020 | 02:48am EDT

By Ben Dummett

Nasdaq Inc. is cleaning up on both sides of the Atlantic.

In the U.S., the stock-exchange operator's Nasdaq indexes are the country's best-performing major stock benchmarks this year. In Europe, the Nasdaq-owned Copenhagen exchange's index is leading the charge.

Like its U.S. counterpart, Denmark's stock exchange is thriving in a coronavirus world. But the narrower base of big stocks behind the gain could make it a riskier bet.

The Copenhagen exchange's OMX Copenhagen 20 index is largely dominated by the health-care sector. High single- and double-digit gains in three constituents -- Novo Nordisk A/S, Genmab A/S and Coloplast A/S -- all of which are health-care stocks, have helped lift the benchmark more than 13% year to date. Meanwhile, Europe's other 18 country equity benchmarks are all trading lower.

That outperformance comes as Europe battles the coronavirus-induced recession, pushing investors into so-called growth and defensive sectors. Health-care stocks are often in that group because sick people can't do without drugs and treatment. Insulin maker Novo Nordisk and Coloplast, a supplier of continence care and other products, both reported higher sales for their latest quarters, citing supply stockpiling as a reason.

Still, the concentration leaves the market index at risk of an abrupt downturn if any of these health-care companies suffer a surprise setback. Novo Nordisk, for example, carries an index weighting of 33%. That compares with a combined weighting of about 40% for the five biggest stocks in the Nasdaq Composite Index -- Apple Inc., Microsoft Corp., Amazon.com Inc., Facebook Inc. and Alphabet Inc. -- big drivers behind its outperformance in 2020. Together with Genmab, a Danish biotech company, and Coloplast, the three health-care stocks' total weighing is close to 50%.

"There is some stock-specific risk that you really need to look out for, " said Kenneth Lamont, a research analyst at Morningstar.

In 2018, Novo Nordisk fell 7.3% in one session on disappointing earnings. Danske Bank at the time blamed the sell off for a big part of a 3% drop in OMXC20 and its underperformance against rival markets that day.

The Xact OMXC25 and iShares MSCI Denmark ETF are exchange-traded funds that allow investors to bet on the Copenhagen exchange. While each ETF tracks more companies than included in the OMXC20, health-care weightings remain the biggest for each.

The OMXC25 trades at around 29 times projected earnings of the constituent companies, compared with a 10-year average of 18.6 times, according to Danske Bank, suggesting valuation is another potential risk. The growth outlook of companies such as Genmab helps to explain the richer valuation. In June, the biotech company struck a $750 million deal with AbbVie Inc. to develop cancer treatments, and the stock is up about 15% since then.

Still, Danske Bank recommends underweighting the Danish market. Growth stocks like health care are expensive, and more cyclical stocks should perform relatively better over the next three to nine months as the economy recovers, said Chief Equity Strategist Mattias Sundling.

Germany's DAX stock index, which has big weightings in industrials and autos, has gained more than 45% from its low in March, outperforming the OMXC20's 37% gain over the same period, in a possible sign of support for that view.

-- To receive our Markets newsletter every morning in your inbox, click here.

Write to Ben Dummett at ben.dummett@wsj.com


Stocks mentioned in the article
ChangeLast1st jan.
ABBVIE INC. -0.45% 86.89 End-of-day quote.-1.86%
ALPHABET INC. 0.50% 1466.02 End-of-day quote.9.45%
APPLE INC. -0.76% 114.09 End-of-day quote.55.41%
COLOPLAST A/S 3.06% 1010 End-of-day quote.18.59%
DANSKE BANK A/S 0.62% 84.5 End-of-day quote.-22.10%
DAX -0.35% 12825.82 End-of-day quote.-3.19%
DJ INDUSTRIAL -0.48% 27452.66 End-of-day quote.-3.80%
FACEBOOK 1.94% 261.79 End-of-day quote.27.55%
GENMAB A/S 0.17% 2354 End-of-day quote.58.62%
MICROSOFT CORPORATION -1.04% 207.26 End-of-day quote.32.81%
MORNINGSTAR, INC. 0.44% 159.3 End-of-day quote.5.28%
NASDAQ -3.18% 121.38 End-of-day quote.13.33%
NASDAQ 100 -0.37% 11322.9537 End-of-day quote.27.69%
NASDAQ COMP. -0.29% 11085.2484 End-of-day quote.23.91%
NOVO NORDISK A/S 0.47% 444.3 End-of-day quote.14.37%
OMX COPENHAGEN 20 0.98% 1366.9578 End-of-day quote.19.18%
S&P 500 -0.48% 3335.47 End-of-day quote.3.74%
share with twitter share with LinkedIn share with facebook
All news about NASDAQ
04:31pNASDAQ : to Hold Third Quarter 2020 Investor Conference Call
04:31pNasdaq to Hold Third Quarter 2020 Investor Conference Call
09/25IPO Market Parties Like It's 1999
09/24NASDAQ : Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as o..
09/24Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as ..
09/23CME, Nasdaq to Launch Water Futures Contract
09/21NASDAQ : Delisting of Securities of Therapix Biosciences Ltd.; Stein Mart, Inc.;..
09/21Delisting of Securities of Therapix Biosciences Ltd.; Stein Mart, Inc.; and S..
09/21Wall Street-backed MEMX launches in challenge to NYSE and Nasdaq
09/21WALL STREET STOCK EXCHANGE : Wall Street-Backed Exchange Launches as Rival to NY..
More news
Financials (USD)
Sales 2020 2 774 M - -
Net income 2020 923 M - -
Net Debt 2020 2 127 M - -
P/E ratio 2020 22,6x
Yield 2020 1,60%
Capitalization 19 938 M 19 938 M -
EV / Sales 2020 7,95x
EV / Sales 2021 7,70x
Nbr of Employees 4 670
Free-Float 67,0%
Duration : Period :
Nasdaq Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NASDAQ
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 135,92 $
Last Close Price 121,38 $
Spread / Highest target 23,6%
Spread / Average Target 12,0%
Spread / Lowest Target -21,7%
EPS Revisions
Adena T. Friedman President, Chief Executive Officer, COO & Director
Michael R. Splinter Chairman
Michael Ptasznik Chief Financial Officer & EVP-Corporate Strategy
Bradley J. Peterson Chief Information Officer & Executive VP
Lars Rune Wedenborn Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
NASDAQ13.33%20 593
B3 S.A. - BRASIL, BOLSA, BALCÃO24.85%20 027